QUARTERLY FINANCIAL DATA

12 Months Ended

Dec. 31, 2015

Quarterly Financial Data [Abstract]

QUARTERLY FINANCIAL DATA

QUARTERLY FINANCIAL DATA

Selected quarterly financial data for the years ended December 31, 2015 and 2014 is as follows:

	For the Year Ended December 31, 2015
	First Quarter (Unaudited)			Second Quarter (Unaudited)			Third Quarter (Unaudited)			Fourth Quarter (Unaudited)
Consolidated Statements of Operations and Comprehensive Income Data:
Net revenues	$	126,133		$	166,834		$	117,322		$	195,552
Cost of revenues	98,828			101,229			85,832			116,654
Operating (loss) / income	(17,239		)	36,441			28,853			46,528
(Loss) / income from continuing operations	(70,243		)	(11,669		)	(21,510		)	1,137
(Loss) / income from discontinued operations, net of tax	(3,288		)	2,684			(265		)	(12,418		)
Net loss	(73,531		)	(8,985		)	(21,775		)	(11,281		)
Net loss attributable to CME Ltd.	(73,274		)	(8,678		)	(21,522		)	(11,427		)
Net loss per share:
Basic EPS	$	(0.53	)	$	(0.09	)	$	(0.18	)	$	(0.11	)
Effect of dilutive securities	—			—			—			—
Diluted EPS	$	(0.53	)	$	(0.09	)	$	(0.18	)	$	(0.11	)

	For the Year Ended December 31, 2014
	First Quarter (Unaudited)			Second Quarter (Unaudited)			Third Quarter (Unaudited)			Fourth Quarter (Unaudited)
Consolidated Statements of Operations and Comprehensive Income Data:
Net revenues	$	140,705		$	192,811		$	131,081		$	216,196
Cost of revenues	119,579			125,514			105,823			138,125
Operating (loss) / income	(14,682		)	22,687			(8,023		)	38,298
Loss from continuing operations	(41,000		)	(41,352		)	(51,308		)	(17,805		)
Loss from discontinued operations, net of tax	(7,633		)	(11,154		)	(1,174		)	(60,470		)
Net loss	(48,633		)	(52,506		)	(52,482		)	(78,275		)
Net loss attributable to CME Ltd.	(47,916		)	(52,437		)	(52,138		)	(74,937		)
Net loss per share:
Basic EPS	$	(0.35	)	$	(0.39	)	$	(0.38	)	$	(0.54	)
Effect of dilutive securities	—			—			—			—
Diluted EPS	$	(0.35	)	$	(0.39	)	$	(0.38	)	$	(0.54	)